🇺🇸 FDA
Patent

US 12297452

Methods or generating T-cells from stem cells and immunotherapeutic methods using the T-cells

granted A61KA61K40/11A61K40/31

Quick answer

US patent 12297452 (Methods or generating T-cells from stem cells and immunotherapeutic methods using the T-cells) held by The Regents of the University of California expires Mon May 08 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue May 13 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 08 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61K, A61K40/11, A61K40/31, A61K40/32, A61K40/42